Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Madhumegha Kudineer Chooranam is a classical Siddha polyherbal formulation manufactured by SKM Siddha & Ayurveda Company India Ltd. It is primarily indicated for the management of diabetes mellitus. The formulation is provided in a powder (chooranam) form, which is traditionally prepared as a decoction (kudineer or kashaya) by boiling with water. It consists of five key herbal ingredients: Bilva (Aegle marmelos), Nilavembu (Andrographis paniculata), Jamun (Syzygium cumini), Mango (Mangifera indica), and Neem (Azadirachta indica). These botanical components are recognized in traditional Siddha medicine for their synergistic hypoglycemic properties, which assist in the regulation of blood glucose levels. The product is referenced in the Siddha Formulary of India, Part-1, and is administered orally.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on madhumegha kudineer chooranam.